Transparency, Power, and Influence in the Pharmaceutical Industry : Policy Gain or Confidence Game? - Katherine Fierlbeck

Transparency, Power, and Influence in the Pharmaceutical Industry

Policy Gain or Confidence Game?

By: Katherine Fierlbeck (Editor), Janice Graham (Editor), Matthew Herder (Editor)

Paperback | 14 June 2021

At a Glance

Paperback


$117.75

or 4 interest-free payments of $29.44 with

 or 

Aims to ship in 10 to 15 business days

There is plenty of controversy surrounding pharmaceuticals, but it cannot be denied that it is both a socially beneficial and profit-making industry. Regulators are expected to ensure that the economic success of the pharmaceutical industry does not come at the expense of public safety, yet regulators have also assumed a cooperative role by providing advice on regulation and by targeting unmet medical needs. Concerns over regulatory standards, conflicts of interest, and the manipulation of information on drug safety and effectiveness have led to public mistrust and a greater need for transparency between pharmaceutical industry and government regulators.

Transparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry responsible for creating transparency in the industry, from development to market. The contributors to this volume examine the various mechanisms introduced to make the regulatory process more informative and situate these efforts within the larger project of enhancing the safety of drugs, vaccines, and other products.

Industry Reviews

Transparency, Power, and Influence in the Pharmaceutical Industry is thoroughly researched, extremely well documented, and well written. The contributors are superbly acquainted with the literature on the subjects they write about, and I know many of them encounter their world as both public-interest academics and advocates, people who pursue studies in the public interest and carry out their academic work in the spirit of making the world a more just place.

- Alan Cassels, Drug Policy Researcher, University of Victoria

A superb evaluation of accountability in the pharmaceutical sector. Fierlbeck, Graham, Herder, and the contributors offer an authoritative and insightful assessment of the limited transparency that prevents us from seeing what is really happening as new drugs are assessed and approved. The authors compare international approaches that offer perspectives on how we can keep our trust in the safety of medicines and the stakeholders involved in regulatory processes.

- Mary E. Wiktorowicz, Professor of Global Health Governance and Policy and Associate Director of the Dahdaleh Institute for Global Health Research, York University

More in Central Government Policies

Capital in the Twenty-First Century - Thomas Piketty

RRP $43.95

$36.75

16%
OFF
Unleashed - Boris Johnson

Paperback

RRP $49.99

$38.75

22%
OFF
Competitive Cities : Succeeding in the Global Economy - Hazel Duffy
Apocalypse Never : Why Environmental Alarmism Hurts Us All - Michael Shellenberger